Wei Zheng
Director/Board Member chez HAISCO PHARMACEUTICAL GROUP CO., LTD.
Fortune : 579 M $ au 31/03/2024
Profil
Wei Zheng currently works at Haisco Pharmaceutical Group Co., Ltd., as Director & Deputy General Manager from 2007, Sichuan Haisco Pharmaceutical Co., Ltd., as Director-Supervisory Board, Liaoning Haisco Pharmaceutical Co., Ltd., as Director-Supervisory Board, Sichuan Kang De Li Pharmaceutical Co., Ltd., as Director-Supervisory Board, and Pneuma Respiratory, Inc., as Director.
Mr. Zheng received his graduate degree from Sichuan Antimicrobial Industry Research Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/01/2024 | 128 158 200 ( 20,11% ) | 481 M $ | 31/03/2024 | |
| 04/01/2024 | 25 970 100 ( 5,45% ) | 97 M $ | 31/03/2024 |
Postes actifs de Wei Zheng
| Sociétés | Poste | Début |
|---|---|---|
| HAISCO PHARMACEUTICAL GROUP CO., LTD. | Director/Board Member | 01/01/2007 |
Sichuan Haisco Pharmaceutical Co., Ltd.
 Sichuan Haisco Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Co., Ltd. is a diversified and specialized pharmaceutical group listed Chinese company that was founded in 2000. The private company is based in Chengdu, China. Sichuan Haisco Pharmaceutical Co. is engaged in new drug research and development, production, manufacturing, and sales. The company's research and development capabilities are among the best in the chemical pharmaceutical industry, and it has a leading market share in the enteral nutrition segment. It is the fifth-largest liver disease drug manufacturer in the country and occupies an important position in the liver disease, digestion, and anti-infection segments. The company has contributed to society by providing assistance to underdeveloped areas and vulnerable groups, donating funds and materials to build schools, supporting poor students, and providing economic and cultural assistance to underdeveloped areas. | Director/Board Member | - |
Liaoning Haisco Pharmaceutical Co., Ltd.
 Liaoning Haisco Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Haisco Pharmaceutical Group Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd. produces drugs and therapeutic products. The private company is based in Xingcheng, China. The CEO of the Chinese company is Yong Liang. | Director/Board Member | - |
| Sichuan Kang De Li Pharmaceutical Co., Ltd. | Director/Board Member | - |
Pneuma Respiratory, Inc.
 Pneuma Respiratory, Inc. Medical SpecialtiesHealth Technology Pneuma Respiratory, Inc. manufactures respiratory healthcare devices. The firm’s applications include COPD and non-small cell lung cancer. It focuses on creating therapeutic treatments for diseases of the lungs using a digital-first platform for inhaled drug delivery. The company was founded by Eric C. Hunter in 2015 and is headquartered in Boone, NC. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HAISCO PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sichuan Haisco Pharmaceutical Co., Ltd.
Sichuan Haisco Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Part of Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Co., Ltd. is a diversified and specialized pharmaceutical group listed Chinese company that was founded in 2000. The private company is based in Chengdu, China. Sichuan Haisco Pharmaceutical Co. is engaged in new drug research and development, production, manufacturing, and sales. The company's research and development capabilities are among the best in the chemical pharmaceutical industry, and it has a leading market share in the enteral nutrition segment. It is the fifth-largest liver disease drug manufacturer in the country and occupies an important position in the liver disease, digestion, and anti-infection segments. The company has contributed to society by providing assistance to underdeveloped areas and vulnerable groups, donating funds and materials to build schools, supporting poor students, and providing economic and cultural assistance to underdeveloped areas. | Health Technology |
Liaoning Haisco Pharmaceutical Co., Ltd.
Liaoning Haisco Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Haisco Pharmaceutical Group Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd. produces drugs and therapeutic products. The private company is based in Xingcheng, China. The CEO of the Chinese company is Yong Liang. | Health Technology |
| Sichuan Kang De Li Pharmaceutical Co., Ltd. | |
Pneuma Respiratory, Inc.
Pneuma Respiratory, Inc. Medical SpecialtiesHealth Technology Pneuma Respiratory, Inc. manufactures respiratory healthcare devices. The firm’s applications include COPD and non-small cell lung cancer. It focuses on creating therapeutic treatments for diseases of the lungs using a digital-first platform for inhaled drug delivery. The company was founded by Eric C. Hunter in 2015 and is headquartered in Boone, NC. | Health Technology |
